Nevill T J, Benstead T J, McCormick C W, Hayne O A
Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Am J Hematol. 1989 Dec;32(4):314-5. doi: 10.1002/ajh.2830320414.
High-dose cytosine arabinoside may benefit patients with refractory acute leukemia. Peripheral nervous system disturbances caused by cytosine arabinoside have rarely been reported. We describe a patient with acute leukemia who developed Horner's syndrome and a severe demyelinating peripheral neuropathy leading to death after receiving high-dose cytosine arabinoside. Peripheral nerve dysfunction is a potentially serious complication of high-dose cytosine arabinoside.